Introduction
Pseudomonas aeruginosa is an opportunistic Gramnegative pathogen responsible for a large number of nosocomial infections. This organism commonly causes disease in the setting of pre-existing epithelial tissue damage, e.g. superinfection of burns, corneal ulcer formation at the sites of contact lens associated trauma, cystitis in catheterized patients, and tracheobronchitis and pneumonia in mechanically ventilated patients (Salyers and Whitt, 1994) . A number of in vitro and ex vivo studies support the notion that injured epithelium is a preferred target for P. aeruginosa infection (Yamaguchi and Yamada, 1991; Zahm et al., 1991; Tsang et al., 1994; de Bentzmann et al., 1996a) , an effect that has been ascribed to increased levels of a putative pilin receptor, asialoGM 1 (de Bentzmann et al., 1996a, b, c) or to the upregulation of fibronectin and the integrin a 5 b 1 during wound repair . Dedifferentiation and loss of polarity in repairing cells may also promote P. aeruginosa adhesion and internalization, as both adhesion and internalization increase in epithelial cells whose polarity has been pharmacologically disrupted 1998a; Plotkowski et al., 1999) .
Despite extensive study of the interactions between P. aeruginosa and injured epithelium, the effect of bacterial infection on epithelial wound healing has received little attention. P. aeruginosa possesses many virulence factors that might cause epithelial injury or impair epithelial wound closure. These include: secreted enzymes, such as the proteases LasA and LasB, which exhibit elastolytic activity; the diphtheria toxin-like Exotoxin A; several phospholipases; and an alkaline protease (Salyers and Whitt, 1994) . P. aeruginosa also expresses a type III secretion system capable of translocating bacterially synthesized effector proteins directly into eukaryotic target cells. The effector proteins that are substrates of this system include a potent cytotoxin, ExoU (Finck-Barbancon et al., 1997; Hauser et al., 1998) ; an adenylate cyclase, ExoY (Yahr et al., 1998) ; and two related proteins, ExoS and ExoT, which are GTPaseactivating proteins (GAPs) with in vitro specificity for the Rho-family GTPases Rac, Rho and Cdc42 (Goehring et al., 1999; Krall et al., 2000) . The last two bacterial proteins might have a significant impact on wound closure, as Rho and Rac activity are required for cell migration during wound repair (Santos et al., 1997; Nobes and Hall, 1999) .
In this study, we test the hypothesis that P. aeruginosa can inhibit the process of wound repair and thus increase its ability to colonize and damage injured epithelium. P. aeruginosa strain PA103, a clinical lung isolate, reverses epithelial wound closure and causes cell loss by disrupting the actin cytoskeleton through a process requiring the GAP activity of the type III-secreted effector ExoT. Activation of Rho-family GTPases with Cytotoxic Necrotizing Factor-1 (CNF-1) prevents cell detachment, as does mutation and inactivation of the GAP domain within ExoT. These results help to explain why P. aeruginosa is such a virulent pathogen in the setting of epithelial cell injury.
Results

PA103 infection of mechanically wounded A549 monolayers inhibits epithelial repair
To test whether P. aeruginosa can alter the process of epithelial wound repair, mechanically wounded monolayers of lung epithelial A549 cells were used; this is a well-characterized system in which wound closure results predominantly from cell migration and spreading, rather than cell proliferation (Kheradmand et al., 1994; Geiser et al., 2000) . Four hours after mechanical wounding, wound area reproducibly decreased by 30±40%, as seen in Fig. 1 (see also Figs 3±5 ). The addition of P. aeruginosa strain PA103 (MOI of 3) (a human lung isolate that elaborates the type III-secreted proteins ExoU and ExoT but lacks the quorum-sensing LasI/LasR system and fails to produce elastase), induced a rapid increase in the area of the wound (Fig. 1) . The bacterially infected cells appeared shrunken with pyknotic nuclei, and cell loss was observed throughout the monolayer (Fig. 2C) , consistent with the known cytotoxic effect of this strain on epithelial cells (Apodaca et al., 1995; Fleiszig et al., 1998b) . Because of the widespread cell damage and cell loss throughout the monolayer, the original wound could no longer be clearly demarcated from other areas of cell loss in the monolayer at $12 h; therefore, no further measurements were taken.
In contrast, cells infected with the isogenic strain PA103pscJ::Tn5, which cannot secrete type III effectors (for PA103, ExoU and ExoT) because of a transposon insertion in the type III secretion (psc) operon, showed continued wound closure after infection, resulting in a 60± 70% decrease in wound size after 24 h (Fig. 1) . The cell morphology at the edge of the wound was indistinguishable from uninfected control cells (compare Fig. 2B and A); however, the uninfected control did achieve a greater degree of wound closure (90±95%) than the PA103pscJ::Tn5-infected samples. The difference in wound closure between uninfected monolayers and PA103pscJ::Tn5-infected monolayers was consistently observed at time points beyond 6 h post infection.
Infection of wounded cells with PA103DU, a strain carrying a large in-frame deletion within the gene encoding the putative cytotoxin ExoU but otherwise intact for type III secretion (Garrity-Ryan et al., 2000) , had a particularly interesting effect on epithelial wound repair. Four hours after infection with PA103DU, the A549 cells at the edge of the wound showed cytoplasmic retraction and cell rounding; similar changes were not seen at this time within portions of the monolayer at a distance from the wound edge (Fig. 2D) . Concomitantly, the area of the wound increased to $100%, as can be seen in Figs 1, 4 and 5.
We asked whether the phenotypes of the mutants varied with the number of bacteria applied to the injured epithelium. However, infection at MOIs up to 30 resulted only in a more rapid appearance of the phenotypes associated with each strain. Neither the morphological changes observed in infected cells nor the final percentage of wound closure measured at 12 or 24 h were altered (data not shown).
Inhibition of wound healing requires live bacteria and active protein synthesis
The data presented so far suggest that a type III-secreted protein may be involved in reversal of wound closure; however, this phenotype may be caused by another bacterial product whose synthesis, localization or secretion is co-regulated with the type III secretion system. We therefore explicitly tested whether inhibition of wound Fig. 1 . Infection of wounded A549 monolayers with PA103 strains inhibits epithelial wound repair in vitro. A549 cells grown as confluent monolayers were mechanically wounded 4 h before infection with PA103 (MOI 3) or the isogenic mutants PA103DU (MOI 3.6) and PA103pscJ::Tn5 (MOI 29). Wound area was measured at 2 4, 0, 2, 4, 6, 12 and 24 h post wounding as described in Experimental procedures. Wound measurements were made on triplicate wells and the area of the wound is expressed as mean per cent of the initial wound area^SD.
healing by P. aeruginosa requires the presence of live bacteria or active bacterial protein synthesis. PA103 or PA103DU was incubated for 20 min in a 658C water bath; this treatment reduced bacterial viability by .10 5 -fold. When the heat-killed bacteria were applied to wounded A549 cells at an MOI of 5±10, no inhibition of wound closure was observed (Fig. 3A) . Microscopic examination of the monolayers did not demonstrate cell rounding, cell shrinkage or pyknotic nuclei (data not shown).
To assess the requirement for active protein synthesis, bacterial cultures were pretreated with chloramphenicol (Cm; 50 mg ml 21 ) for 45 min and then applied to the wounded epithelial monolayer in the continued presence of drug. While Cm itself had no effect on wound healing, Cm-treated PA103 and PA103DU failed to inhibit wound healing (Fig. 3B) or to cause changes in cell morphology (data not shown).
The wound closure curves of both heat-killed bacteria and Cm-treated bacteria were superimposable upon those obtained for uninfected monolayers over 8 h of experimental observation. These data suggest that the type III secretion-independent plateau in wound closure observed with PA103pscJ::Tn5 requires bacterial protein synthesis. It was not possible to extend these studies to 24 h as Cm-resistant bacteria appeared during the course of the experiment (data not shown). The PA103 type III-secreted protein ExoT is required to inhibit epithelial wound repair
The differences in the behaviour of PA103pscJ::Tn5 and PA103DU-infected monolayers led us to test whether one of the type III-secreted proteins elaborated by PA103DU, and absent in PA103pscJ::Tn5, could mediate cell rounding and inhibition of wound closure. ExoT, a Rhofamily GAP (Krall et al., 2000) that causes cell rounding of HeLa and Chinese Hamster ovary (CHO) cells (Vallis et al., 1999; Garrity-Ryan et al., 2000) , was the most likely candidate. We constructed PA103DUDT, a strain that no longer synthesizes ExoT by virtue of a gentamicin cassette insertion into the exoT gene. Infection with the double mutant resulted in a phenotype indistinguishable from that seen with PA103pscJ::Tn5. There was no change in cell morphology at the wound edge (data not shown), and wound closure proceeded at the same rate for cells infected with either strain (Fig. 4A) .
To determine whether ExoT was required for cell rounding and inhibition of wound healing, the strain PA103DUDT transformed with pUCP20-ExoT or vector alone was added to wounded A549 monolayers, and the effect on wound healing between the mutant and complemented strains was compared. The PA103DUDT-pUCP20 control strain did not increase the area of the wound, and wound size plateaued at 4±6 h post infection at approximately 45% wound closure. However, the complemented strain PA103DUDT-pUCP20-ExoT showed complete reversal of wound closure by 4±6 h post infection, similar to PA103DU. Microscopic examination showed typical morphological changes: the complemented strain caused cell rounding and cytoplasmic retraction indistinguishable from that observed after infection with PA103DU (data not shown). These results demonstrate that ExoT is required for PA103 both to inhibit wound closure and to induce cell rounding preferentially in cells along the wound edge.
ExoT-mediated cell detachment can be reversed by CNF-1
Our finding that ExoT-mediated inhibition of wound closure occurs rapidly (within 4 h of bacterial infection) and is associated with marked changes in cell shape suggests that alterations in the actin cytoskeleton affecting cell attachment (rather than changes in cell proliferation) are important in this process. To test this hypothesis, A. Heat-inactivated bacteria. Aliquots of PA103 and PA103DU were split, and either heated to 688C or maintained at room temperature for 20 min before infecting wounded monolayers. B. Chloramphenicol-treated bacteria. Bacteria were diluted to an approximate MOI of 5±10 in tissue culture media and incubated at 378C in the presence or absence of Cm (50 mg ml
21
) for 45 min before inoculation of A549 monolayers wounded 4 h previously. Cm was maintained in the samples at 50 mg ml 21 throughout the experiment; this did not alter the rate of wound closure as can be seen by comparing the medium vs. medium plus Cm curves (P . 0.1 at all time points, Student's two-tailed t-test). At all time points, neither Cm-treated bacterial sample differed significantly from the Cm-treated uninfected control (P $ 0.08 for all two-way comparisons, Student's two-tailed t-test).
culture supernatants were collected 4 h after addition of bacteria and detached cells counted. Infection with PA103DU resulted in significant cell detachment compared with uninfected controls (P 0.008, Student's twotailed t-test) (Fig. 5 ). This effect was not observed after infection with strains that did not inhibit wound closure or cause cell rounding, such as PA103DUDT or PA103pscJ::Tn5. It has been reported that inactivation of the GTPase Rho inhibits wound closure by causing migrating cells to detach from their substrate (Nobes and Hall, 1999) . We hypothesized that if ExoT was causing cell rounding and detachment by acting as a GAP for Rho, then these phenotypes should be prevented by pretreating the cells with an agent that activates Rho, such as Cytotoxic Necrotizing Factor-1 (CNF-1). As seen in Fig. 5 , cells pretreated with CNF-1 for 15 h before wounding no longer showed detachment above baseline when infected by the ExoT-expressing strain, PA103DU (P 0.14, Student's two-tailed t-test). Microscopic examination demonstrated that PA103DU-associated cell rounding was also attenuated in CNF-1 pretreated cells compared with untreated infected cells (data not shown). We did not measure the effect of CNF-1 on wound closure after infection, however, because both activation and inactivation of Rho result in impaired cell migration (Nobes and Hall, 1999) . A. PA103DUDT infection allows epithelial wound closure to occur. A549 monolayers were wounded 4 h before infection with PA103DU, PA103DUDT or PA103pscJ::Tn5. Wound area was measured at indicated time points and is expressed as mean per cent of initial wound area. Each point represents the mean of triplicate wells^SD. B. Expression of ExoT from a plasmid restores the ability of PA103DUDT to inhibit wound closure. PA103DUDT carrying the plasmid pUCP20-ExoT or the empty vector (pUCP20) were used to infect wounded A549 monolayers. All samples, including the uninfected control, contained carbenicillin (200 mg ml 21 ) to select against plasmid loss during the course of the experiment.
The conserved residue Arg149 of ExoT is required to inhibit wound healing
The observation that activation of Rho by CNF-1 pretreatment of cells prevents cell rounding and detachment of PA103DU-infected cells suggests that the GAP activity of ExoT mediates these phenotypes after bacterial infection. We tested this hypothesis by constructing PA103DU strains in which Arg149 within the arginine finger motif of the GAP domain had been mutated to either lysine [PA103DU/T(R149K)] or glycine [PA103DU/ T(R149G)], a change that is predicted to abolish the GAP activity of ExoT. Western blot analysis of secreted proteins prepared from PA103DU, PA103DU/T(R149G) and PA103DU/T(R149K) showed that ExoT was secreted into the media in comparable amounts by all three strains, suggesting that the wild-type and mutant proteins are equally competent for secretion (data not shown). In vivo measurement of Rho-GTP levels using a rhotekin-based assay (Ren et al., 1999) confirmed that the Rho-GAP activity observed in HeLa cells transfected with the wild-type ExoT gene was no longer present in cells transfected with constructs encoding either ExoT(R149K) or ExoT(R149G) (B. Kazmierczak and J. Engel, in preparation). Both point mutants abolish the rapid and complete reversal of wound closure seen with the parental strain PA103DU (Fig. 6) . Moreover, the wound healing curves obtained in their presence are indistinguishable from those seen with the strain completely lacking ExoT. Examination of the wounded monolayers showed cell rounding along the edge of the wound 4±6 h post infection with PA103DU; these changes were absent from samples infected by either point mutant or by PA103DUDT. However, the appearance of migrating cells differed between samples infected by the two point mutants and PA103DUDT. In A549 monolayers infected with PA103DU/T(R149G) or PA103DU/T(R149K), many cells possessed a markedly elongated shape. These cells appeared to migrate into the wound area as individual cells rather than as a cell sheet, the pattern commonly observed with the DUDT double mutant (data not shown).
The actin cytoskeleton and focal adhesions of infected cells are altered by bacteria expressing wild-type ExoT or ExoT mutated at Arg149
Although point mutations in ExoT at Arg149 abolished the ability of PA103DU to reverse epithelial wound healing, they did not result in a phenotype indistinguishable from that of the double mutant strain PA103DUDT. We therefore decided to examine the effects of these different bacterial strains on the morphology of healing monolayers. Wounded A549 monolayers were fixed at several time points after bacterial infection and the actin cytoskeleton visualized by phalloidin staining. Five hours post infection, migrating A549 cells were clearly visible at the wound margins; phalloidin staining revealed lamellipodia at the leading edge of the cells and prominent stress fibres appearing to terminate in focal adhesions ( Fig. 7A and E). The cells maintained a well-spread morphology and many cell±cell contacts during migration. Monolayers infected by PA103DUDT had a similar appearance, with well-spread cells appearing to migrate away from the wound margin ( Fig. 7C and G) . In contrast, PA103DU-infected monolayers showed markedly altered A549 cell morphology along the wound margin: cells were rounded, with collapse and retraction of the cytoskeleton (Fig. 7B  and F) . No stress fibres were visible, even in cells that
were not yet rounded. Cells migrating into the wound area in the PA103DU/T(R149K)-infected samples often appeared more elongated than those infected by PA103DUDT, and exhibited fewer cell±cell contacts during migration than control monolayers (Fig. 7D and Fig. 6 . Mutation of Arginine149 in ExoT abolishes the ability of P. aeruginosa to inhibit epithelial wound closure in vitro. A549 monolayers were wounded 4 h before infection with PA103DU, PA103DUDT, PA103DU/T(R149K) or PA103DU/T(R149G) at an MOI of 1±3. Wound area was measured over 24 h in triplicate wells and is expressed as mean per cent of initial wound areâ SD. At 12 and 24 h post infection, the wound area in PA103DU-infected samples differs significantly from the wound area observed in PA103DUDT-infected samples (P # 0.0001, Student's two-tailed t-test) or in samples infected with either Arg149 point mutant (P , 0.003, Student's two-tailed t-test). There is no statistically significant difference at these time points between the Arg149-infected samples and samples infected with PA103DUDT (P . 0.9 for all two-way comparisons, Student's two-tailed t-test).
H). Rounded cells were present, though not to the same extent as in samples infected by PA103DU, and many cells had visible stress fibres (Fig. 7H) . Similar morphology and migration patterns were observed after infection with the other point mutant, PA103DU/T(R149G) (data not shown).
We also examined focal adhesions in the wounded epithelial cell monolayers by fixing cells after infection, Fig. 7 . A549 cells bordering the wound area assume different morphologies after infection with P. aeruginosa depending on the genotype at exoT. Confluent monolayers of A549 cells grown on fibronectin-coated eight-chamber slides were mechanically wounded 4 h before bacterial infection (MOI 10). Samples were fixed and stained as described in Experimental procedures, and imaged using a Nikon Eclipse E800 microscope (400Â). Green staining indicates Syto9 (nuclear) staining of eukaryotic and bacterial DNA; red staining indicates F-actin staining by phalloidin. Panels E-H are enlarged to show detail. Arrows show stress fibres in control cells (E) and in cells infected with either PA103DUDT (G) or PA103DU/T(R149K) (H). A and E. Uninfected control, 5 h post mock-infection. B and F. PA103DU, 5 h post infection. C and G. PA103DUDT, 5 h post infection. D and H. PA103DU/T(R149K), 5 h post infection. Fig. 8 . Paxillin staining and focal adhesion appearance are altered by PA103 infection depending on the genotype at exoT. Confluent monolayers of A549 cells grown on fibronectin-coated eight-chamber slides were mechanically wounded 4 h before bacterial infection (MOI 10). Samples were fixed and stained as described in Experimental procedures 8 h post infection. Anti-paxillin staining (green), F-actin staining with phalloidin (red) and DAPI staining of nucleic acids (blue) were imaged with a Nikon Eclipse E800 microscope (400Â). Panels E-H are enlarged to show detail. The diffuse paxillin staining visible in PA103DU/T(R149K)-infected cells (H) is clearly different from the discrete focal adhesion staining pattern present in uninfected (E) or PA103DUDT-infected cells (G). Some paxillin staining is visible in areas devoid of cells (E); this is probably a result of residual paxillin being retained on the coverslip in areas where cell loss occurred.
(A and E). Uninfected control. (B and F). PA103DU. (C and G). PA103DUDT. (D and H). PA103DU/T(R149K).
and staining the samples with monoclonal antibodies to paxillin and focal adhesion kinase (FAK), components of focal adhesions. As seen in Fig. 8A and E, the majority of cells at the wound margin showed discrete paxillin staining at focal adhesions and maintained a well-spread morphology. The PA103DUDT-infected cells looked very similar, with paxillin staining predominantly confined to discrete focal adhesions in the cells at the edge of the wound (Fig. 8C and G) . In contrast, cells infected with PA103DU/T(R149K) or PA103DU/T(R149G) showed diffuse paxillin staining with relatively few discrete focal adhesions ( Fig. 8D and H; data not shown) . The elongated cell morphology and absence of cell±cell contacts were again apparent. Cells in PA103DU-infected monolayers showed almost no focal adhesions on paxillin staining ( Fig. 8B and F) ; characteristic cell rounding was visible, with spindly projections presumably marking cytoplasmic retraction and cytoskeleton collapse. Staining of infected cells with antibodies to FAK revealed a similar focal adhesion staining pattern to that seen with staining of paxillin (data not shown). Together, these findings suggest that the GAP domain of ExoT is required for P. aeruginosa to inhibit epithelial wound healing in vitro, and is critical for the cell rounding phenotype and detachment we observed. However, other domains or activities of ExoT may also contribute to alteration of the cell cytoskeleton during epithelial wound closure because the Arg149 mutants clearly alter the distribution of focal adhesions during cell migration and wound closure.
Discussion
P. aeruginosa inhibits wound closure
Although it is well known that intact epithelial tissues present a relative barrier to infection by P. aeruginosa (Salyers and Whitt, 1994) , we demonstrate the novel finding that P. aeruginosa can perpetuate pre-existing injury by inhibiting epithelial wound repair through the type III-secreted protein ExoT. The most striking effect of P. aeruginosa infection on wounded A549 lung epithelial cell monolayers was reversal of previously initiated wound closure. This effect was independent of the type IIIsecreted cytotoxin ExoU, as A549 cells at the wound margin retracted, rounded up and detached after infection with PA103DU, resulting in marked increases in epithelial wound size. Cells distal to the wound edge did not initially show these morphological changes. These results suggest that either the bacteria have preferential access to the cells at the wound edge, or that these cells are more susceptible to bacterial damage. The effect of P. aeruginosa infection on epithelial wound repair was attenuated if bacteria were applied to the monolayer immediately after wounding (T. Geiser and B. Kazmierczak, unpublished results). Therefore, the initiation of wound repair ± which is known to require the activation of many cell pathways, including those regulating the actin cytoskeleton ± may make cells more susceptible to the effects of PA103DU.
We note that PA103 strains that expressed no type IIIsecreted toxins, such as PA103pscJ::Tn5, nonetheless prevented the complete closure of wounded A549 monolayers. This inhibition required the presence of live bacteria actively synthesizing proteins, suggesting that a protein product of PA103 is responsible for this phenotype. Because there was no obvious alteration of cell morphology or migration pattern in these cells, we cannot speculate further upon the mechanism responsible for this arrest of wound closure. It has recently been reported that, in an in vitro model of airway epithelial cell wound closure, culture supernatants of elastase-producing P. aeruginosa strains PAO1 and AK43 can slow cell migration by a mechanism postulated to involve activation of the matrix metalloproteinase MMP-2 (de Bentzmann et al., 2000) . Although PA103 (LasR±) does not secrete elastase, perhaps the activity of one of the other proteases secreted by this strain in a type III-independent manner contributes to the slowing and prevention of complete wound healing that we observe in PA103pscJ::Tn5-infected monolayers.
ExoT: a Rho-family GTPase-activating protein (GAP) mediates inhibition of wound closure
ExoT was responsible for both reversing wound closure and causing cell retraction and rounding. This type IIIsecreted protein has been shown to act as an antiinternalization factor for PA103 (Cowell et al., 2000) and is capable of inhibiting bacterial internalization in both epithelial and macrophage-like cell lines (Garrity-Ryan et al., 2000) . ExoT-expressing strains also cause cell rounding and changes in actin cytoskeleton architecture in epithelial cells (Vallis et al., 1999; Garrity-Ryan et al., 2000) . Because of the changes we observe in the migrating A549 cells, the ability of ExoT to modulate the actin cytoskeleton is probably important for inhibition of epithelial wound healing.
ExoT has two distinct domains. The carboxyl-terminal half of ExoT is highly homologous to the ADP-ribosyltransferase domain of the P. aeruginosa protein, ExoS (Radke et al., 1999) ; however, ExoT has greatly reduced in vitro ADP-ribosyltransferase activity as a result of mutations in the enzymatic active site. The aminoterminal half of ExoT contains a second region of homology to ExoS, an arginine finger domain motif that is characteristic of GTPase-activating proteins (GAPs) found in other bacteria as well as in eukaryotic cells (Fu and Galan, 1999 ). The bacterial GAPs described to date inactivate eukaryotic small-GTPases of the Rho-family, including Rho, Rac and Cdc42, which are master regulators of the actin cytoskeleton. ExoT has recently been shown to have in vitro GAP activity towards Rho, Rac and Cdc42 (Krall et al., 2000) . Mutation of a conserved arginine residue within the arginine finger motif is sufficient to abolish the in vitro GAP activity of ExoS (Ganesan et al., 1999) , Yersinia enterocolitica YopE (Black and Bliska, 2000; von Pawel-Rammingen et al., 2000) , and Salmonella typhimurium SptP (Fu and Galan, 1999) . Although homologous arginine mutants in ExoT have not yet been assayed for in vitro loss of GAP activity, these mutations abrogate the GAP activity of ExoT towards Rho in an in vivo assay (B. Kazmierczak and J. Engel, in preparation). Furthermore, bacteria mutated at Arg149 in ExoT exhibited attenuated anti-internalization activity and eukaryotic cell rounding when co-cultivated with epithelial cells (Garrity-Ryan et al., 2000) .
In this study, we found that bacteria expressing ExoT mutated at Arg149 no longer inhibited epithelial wound closure and failed to induce cell rounding and actin cytoskeleton collapse, consistent with the loss of ExoT GAP activity toward Rho. Because Rho activity is required for migrating cells to adhere to substrate during wound closure, inhibition of Rho by ExoT would be sufficient to account for the cell rounding, detachment and consequent inhibition of wound closure that we observed. Activation of Rho-family GTPases by CNF-1, which should render Rho insensitive to the GAP activity of ExoT, prevented cell detachment, confirming the involvement of this family of proteins in these processes.
Interestingly, differences exist between wounded epithelial cells infected with either Arg149 point mutant compared with those infected by a strain no longer expressing the ExoT protein. Although the wound healing curves of the arginine point mutants did not differ quantitatively from those obtained with the ExoT deletion strain, the migrating cells assumed an elongated, rather than broadly spread, morphology and moved into the wound area as individual cells. This was accompanied by a marked change in paxillin and FAK staining of focal adhesions. Uninfected cells and cells infected by PA103DUDT showed multiple well-defined focal adhesions; in marked contrast, cells infected by the point mutants PA103DU/T(R149G) or PA103DU/T(R149K) showed diffuse paxillin and FAK staining and contained few discrete focal adhesions. It is not unexpected that cells lacking focal adhesions could continue to migrate; this has been shown experimentally for primary rat embryo fibroblasts, which can complete wound closure in an in vitro wound healing model even when focal adhesion formation is inhibited with the ROCK inhibitor Y-27632 (Nobes and Hall, 1999) . However, it is not clear how infection with the Arg149 point mutants causes this change in focal adhesions. Focal adhesion formation is regulated by Rho activity. We have found, however, that the Arg149 point mutants no longer show GAP activity for Rho in vivo (B. Kazmierczak and J. Engel, in preparation). Moreover, stress fibres ± another Rho-dependent structure ± can be visualized in many of the migrating cells, including those that are intimately associated with bacteria (see Fig. 7H ), again arguing that the Arg149 mutants are not acting as GAPs for Rho. Focal adhesion assembly and maintenance are also dependent upon other signal transduction pathways, most notably those regulating tyrosine phosphorylation of focal adhesion components. It is possible, therefore, that ExoT interferes with focal adhesion formation through such a pathway, either directly or by mediating the interaction of another protein (bacterial or eukaryotic) with focal adhesion components.
The roles of ExoT in pathogenesis
The data in this study indicate a novel phenotype of ExoTproducing P. aeruginosa, namely an ability to reverse the closure of epithelial wounds. The capacity to inhibit wound closure might be critical for the pathogenesis of P. aeruginosa in vivo. This pathogen is relatively incapable of breaching intact epithelial tissues and must either rely on pre-existing epithelial damage or itself inflict damage through the action of elaborated cytotoxins in order to efficiently establish disease (Salyers and Whitt, 1994) . Recent in vivo data have suggested that ExoT plays a role in virulence in the mouse model of acute pneumonia. In bacteria lacking the cytotoxin ExoU (and therefore incapable of eliciting de novo epithelial tissue damage through this mechanism), the presence or absence of ExoT influences the ability of bacteria to disseminate to distant organs from the lung (Garrity-Ryan et al., 2000) . PA103DU strains are four times more likely to be recovered from the liver than PA103DUDT strains. Because these bacteria are recovered in equal numbers from the lung, it is unlikely that a difference in the ability to survive and proliferate in the host accounts for differential recovery from the liver. Preferential recovery of PA103DU from the liver may reflect an advantage conferred by the anti-internalization activity of ExoT, which would allow these bacteria to escape phagocytosis by cells of the immune system (Garrity-Ryan et al., 2000) . Alternatively, the ability of ExoT possessing bacteria to prolong epithelial tissue damage incurred during lung infection may permit the bacteria to breach the defence otherwise provided by an intact or repaired epithelial tissue.
The pathogenesis of P. aeruginosa infections is multifactorial: both host defences and pathogen virulence factors contribute to this process in a complex fashion. Based on our results, we propose that ExoT makes critical contributions to pathogenesis. As an anti-internalization factor, ExoT can decrease the likelihood of P. aeruginosa internalization by both professional phagocytes and epithelial cells. This property probably increases the ability of P. aeruginosa to escape local host defences and to shield it from the immune system. ExoT can also interfere with Rho-mediated host cell events, such as those occurring during wound healing, perpetuating tissue injury and epithelial layer disruption. This role might be particularly relevant to the ability of this pathogen both to exploit the opportunities presented by even minor damage to epithelial tissues during infection and to disseminate. Together, these observations begin to explain why P. aeruginosa is such a virulent pathogen in the setting of epithelial tissue compromise.
Experimental procedures
Bacterial strains and plasmids Pseudomonas aeruginosa strains were routinely cultured in Luria±Bertani broth (LB) or Vogel±Bonner minimal medium (VBM) with antibiotics as needed. The following antibiotic concentrations were used: ampicillin (Ap), 100 mg ml 21 , for Escherichia coli; carbenicillin (Carb), 200 mg ml 21 , for P. aeruginosa; gentamicin (Gent), 15 mg ml 21 , for E. coli; and 100 mg ml 21 for P. aeruginosa. All antibiotics were purchased from Sigma (St Louis, MO). A list of strains and constructs used in this study is shown in Table 1 . All cloning steps were carried out in XL2-Blue ultracompetent E. coli (Stratagene).
Construction of PA103DU/T(R149G) and PA103DU(R149K)
Standard molecular biology techniques were used to construct PA103DU/T(R149G) and PA103DU/T(R149K) (Maniatis et al., 1982) . All restriction enzymes were purchased from New England Biolabs (NEB) unless otherwise noted. Isolation of DNA from gel-purified fragments was carried out with Qiaex II Gel Extraction Kit (Qiagen) as per the manufacturer's instructions. All polymerase chain reaction (PCR) amplifications were carried out in a GeneAmp PCR System 9700 thermocycler (PE Applied Biosystems). PCR primers were obtained from Operon. Primer sequences are listed in Table 2 ; bases shown in lower case are not homologous to the chromosomal sequence.
The conserved arginine (R149) of the predicted arginine finger motif found in ExoT was mutated to glycine and lysine as follows. PA103 genomic DNA (template) was prepared as described by Chen and Kuo (Chen and Kuo, 1993) . PCR amplification was carried out as 50 ml reactions containing 200 ng of template DNA, 10% dimethyl sulphoxide (DMSO), 10Â Pfu buffer, 250 nM primers, 200 nM dNTPs (each). A 1:8 mixture (units) of Pfu: AmpliTaq (PE Roche) was used; reactions were run for 30 cycles. PCR primers (Operon) were designed to create a unique restriction enzyme site (BamHI for R149G; AflII for R149K) at the point of mutation.
The R149G mutation was introduced by amplifying PA103 ExoT with BAKA 22 and BAKA 24 (625 bp product) and BAKA 23 and BAKA 25 (934 bp product), gel-purifying the products, digesting them with BamHI (Gibco BRL), ligating the two products together using T4 DNA ligase (NEB), and gel-purifying the fragment corresponding to the predicted 1559 bp product. This fragment was subsequently amplified using the internal primers BAKA 32 and BAKA 33, and the resulting 1075-bp fragment was gel purified before being Atailed with AmpliTaq polymerase and subcloned into pGEM-T (Promega). The sequence of the insert was confirmed at this point. A NsiI±NgoMIV fragment comprising the first 1024 bp of the ExoT coding sequence and containing the R149G mutation replaced the corresponding fragment of pUCP20-ExoT, a plasmid containing the wild-type PA103 ExoT gene under control of its native promoter, to create pBK162.
To introduce the R149G point mutation into the PA103DU chromosome, an internal 939 bp XmaI fragment of the ExoT gene containing the mutation was subcloned from pBK162 into the unique XmaI site of pEX100T to create pBK163. This plasmid was transformed into E. coli S17.1 to enable it to be mated into PA103DU. Exconjugants were selected on VBM plus carbenicillin (200 mg ml 21 ), then streaked to VBM plus 5% sucrose to select for loss of vector sequences through a second recombination event. Sucrose-resistant, carbenicillinsensitive colonies were screened for the presence of the R149G point mutation by PCR amplification of colonies with BAKA 32 and BAKA 33; the PCR product from colonies carrying the mutation could be restricted with BamHI. The presence of the mutation was confirmed by sequencing the BAKA 32/BAKA 33 PCR product from PA103DU/T(R149G) (data not shown).
A similar strategy was used to create PA103DU/T(R149K). The initial PCR was performed using primer pairs BAKA 22 and BAKA 26, and BAKA 23 and BAKA 27; the resulting fragments were restricted with AflII before ligation. The correct ligation product was amplified with BAKA 32 and BAKA 33, A-tailed, subcloned into pGEM-T and sequenced. Of note, the subcloned PCR product contains a second mutation, A211V, which was judged to be a conservative change; this mutation persists in pBK151 and is also found in the chromosome of PA103DU/T(R149K) (data not shown).
Preparation of A549 alveolar epithelial-like cells
A549 human alveolar epithelial-like cells (American Type Culture Collection, Rockville, MD) were grown to confluency in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 50 IU ml 21 penicillin and 50 IU ml 21 streptomycin. Cells were plated to 24-well tissue culture dishes (Falcon) for wounding assays at a density of 1.0±1.2 Â 10 5 cells per well. A confluent monolayer was obtained after 24 h. All media components were purchased from the UCSF Tissue Culture Facility (San Francisco, CA). All tissue culture was carried out at 378C in a humidified atmosphere containing 5% CO 2 .
Wound healing assay
Wound healing in A549 epithelial cells was measured as P. aeruginosa ExoT inhibits epithelial wound repair 233 described previously (Kheradmand et al., 1994; Geiser et al., 2000) . Experiments were carried out in triplicate. Confluent cell monolayers of A549 epithelial cells were washed three times with MEM Eagle's to remove serum and antibiotics, and a linear wound was made with a plastic pipette tip. After wounding, the cells were washed three times to remove the cell debris. The wounded cells were then incubated in MEM Eagle's plus 10% FBS for 4 h at 378C and 5% CO 2 . Preliminary experiments indicated that the effect of P. aeruginosa infection was most consistent if the cells were infected 4 h after wounding (data not shown). After this time, cells were infected with PA103 strains grown overnight at 378C in LB as standing cultures. Bacteria were diluted with MEM Eagle's plus 10% FBS and the MOI determined by titering the dilution; an inoculum of 100 ml of bacteria per well (24-well plate) at an OD 600 of 0.03±0.04 corresponded to an MOI of < 10. The infected cells were maintained at 378C in 5% CO 2 during the experiment. Experiments using plasmid-bearing strains were carried out in the presence of carbenicillin (200 mg ml 21 ) to select against plasmid loss; as can be seen in Fig. 4B , the presence of antibiotic did not itself affect wound healing.
The area of the denuded surface was measured immediately after wounding and before infecting the cells, followed by measurements 2, 4, 6, 8 and 24 h after infection. The cells were imaged using an inverted microscope (Axiovert 35, Zeiss, Thornwood) connected to a charge-coupled device camera (C 2400; NEC, Hawthorne, CA). The image was subsequently captured by an image-analysing frame-grabber card (LG-3 Scientific Frame Grabber; Scion, Frederick, MD) and analysed using an image analysis software (NIH IMAGE 1.55). Wound repair was expressed as percentage of initial wound area in each well. Data from a single experiment representative of three or more independent experiments are shown. Table 2 . Primer sequences used in this study.
Cell detachment assay A549 cells were plated in triplicate as described for wound healing assays. Fifteen to 18 h before wounding, CNF-1 (a generous gift of Peter Flynn and David Stokoe, University of California, San Francisco Cancer Center) was added to cells at a final concentration of 0.3 nM as indicated. Cells were wounded as described above. Four hours after wounding, wells were washed three times with MEM Eagle's plus 10% FBS to remove unattached cells and then infected with bacteria (MOI 1±3). Four hours post infection the media from each well were collected; the wells were rinsed once with fresh media, and these were then combined and spun 5 min at 1000 r.p.m. in a Sorvall RT6000B table top centrifuge to pellet detached cells. The pellets were resuspended in 100 ml of phosphate-buffered saline (PBS) and the number of cells present in each determined by counting with a haematocytometer.
Indirect immunofluorescence
A549 cells were plated on fibronectin-coated eight chamber slides (Lab-Tek Chamber Slides, Nalge Nunc International, Naperville, IL). When confluent, the cells were mechanically wounded as above, then infected 4 h later with bacteria at a final MOI of < 10. The slides were incubated at 378C in 5% CO 2 for the indicated intervals; they were then removed, washed three times with ice-cold PBS and fixed for 30 min at room temperature with 4% paraformaldehyde (Sigma) in PBS. The fixation was quenched with 75 mM NH 4 Cl/20 mM glycine in PBS for 10 min. Slides were blocked and permeabilized in PBS/0.7% Fish Scale Gelatin (Sigma)/ 0.025% Saponin (PFS) plus RNAse (100 mg ml 21 ) for 15± 30 min at 378C. Incubations with primary antibodies were carried out in PFS for 60±90 min at 378C and followed by four washes with PFS. Anti-paxillin antibody (Transduction Labs, #P13520) was used at 1:250, as was anti-FAK antibody (Transduction Labs, #F15020). Incubations with Alexa 488 anti-mouse IgG (Molecular Probes, OR, 1:500) were carried out in PFS for 30±45 min at 378C. Samples were also routinely stained with Syto9 (1:500) (Molecular Probes) or DAPI (1 mg ml 21 , Sigma) and Texas red phalloidin (1 : 200) (Molecular Probes) during incubation with secondary antibody. Samples were then washed twice with PFS followed by two brief washes with 0.1% Triton X-100 (Sigma) in PBS. Coverslips were mounted with Prolong Antifade (Molecular Probes). Samples were imaged on a Nikon Eclipse E800 microscope with a Nikon 40Â Plan fluor objective, captured with a Spot CCD camera (Diagnostic Instruments) using SPOT ADVANCED 3.0.4 software and pseudocoloured and assembled into figures using ADOBE PHOTOSHOP 5.0.
Statistics
Data are presented as mean^SD. Statistical analysis was done using the unpaired Student's t-test or ANOVA, where appropriate. The results were considered statistically significant if P , 0.05.
